Molecular regulation of eosinophil production: a basis for intervention in inflammatory disease

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Eosinophils are rare blood cells that play a key role in the pathology of asthma and other inflammatory diseases. Asthma afflicts hundreds of millions of people worldwide, and excess eosinophils are common in many patients. We aim to define the cells involved in eosinophil development, and we will use cutting-edge technologies to identify new eosinophil regulators that may serve as drug targets or as novel entry points for development of therapeutics for asthma or other inflammatory diseases.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $609,281.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Systems Biology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

asthma | eosinophils | haematopoiesis | inflammation | mouse models | systems biology